Bionet Stock Target Price and Analyst Consensus
| 1784 Stock | TWD 66.40 3.00 4.32% |
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Bionet price targets
Bionet's stock target price is an estimate of its future price, usually made by analysts. Using Bionet's target price to determine if it is a suitable investment can be done through the following steps:- Look at Bionet's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bionet's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Bionet Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bionet is a key component of Bionet valuation and have some predictive power on the future returns of a Bionet.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bionet's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Adviser Favorites Invested few shares | |
 | Momentum Invested over 40 shares | |
 | Power Assets Invested over 200 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Chemicals Invested over 40 shares | |
Check out Macroaxis Advice on Bionet to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Bionet Stock analysis
When running Bionet's price analysis, check to measure Bionet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionet is operating at the current time. Most of Bionet's value examination focuses on studying past and present price action to predict the probability of Bionet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionet's price. Additionally, you may evaluate how the addition of Bionet to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
The data published in Bionet's official financial statements usually reflect Bionet's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Bionet. For example, before you start analyzing numbers published by Bionet accountants, it's critical to develop an understanding of what Bionet's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Bionet's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bionet's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Bionet's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bionet. Please utilize our Beneish M Score to check the likelihood of Bionet's management manipulating its earnings.